Big pharma is racing for contingency plans as the EU's drug administration prepares to uproot from its headquarters in Britain, drawing fears of delays to medicine supplies and the already long development cycle for new treatments.
01:14
01:37
01:17
00:59
00:59
01:29
01:54
01:12
01:17
01:42
00:56
01:39
02:00
02:19
01:13
01:13
01:36
01:00
01:03
00:58
00:36
01:32
01:33
01:24
01:18
00:56
01:06
01:13
01:38
02:53
01:59
01:10
00:57
00:56
01:57
00:52
01:17
01:35
01:08
01:25
01:37
01:17
00:59
01:29
00:56
01:00
01:03
00:58
00:39
01:59
01:39
00:58
01:07
00:46
00:22
01:21
00:46
01:27
00:53
01:00
01:01
01:11
01:14
01:54
01:39
05:58
01:19
01:05
01:54
01:11
01:18
01:36
02:05
01:58
01:07
01:11
01:52
01:29
01:13
01:15
01:39
01:18
02:14
01:00
01:01
01:10
01:42
01:08
01:00
01:31
01:37
01:34
01:27
00:23
01:21
00:52
02:00
01:05
01:44
01:29
01:15
01:18
03:11
01:44
01:34
01:15
01:20
01:20
03:01
00:51
00:50
01:26
01:18
02:49
00:59
02:19
02:19
01:59
00:49
00:38